These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7025019

  • 1. Cytoprotection by sulglycotide: prevention of gastric necrosis in rat.
    Niada R, Malandrino S, Nardi GF, Mantovani M, Prino G, Omini C, Berti F.
    Pharmacol Res Commun; 1981 Jul; 13(7):695-704. PubMed ID: 7025019
    [No Abstract] [Full Text] [Related]

  • 2. Sulglycotide displays cytoprotective activity in rat gastric mucosa.
    Niada R, Mantovani M, Prino G, Omini C, Berti F.
    Int J Tissue React; 1983 Jul; 5(3):285-8. PubMed ID: 6360935
    [Abstract] [Full Text] [Related]

  • 3. Cytoprotective activity of deboxamet: a possible interference with prostaglandin and prostacyclin metabolism in rat gastric mucosa.
    Franzone JS, Cirillo R, Cravanzola C.
    Int J Tissue React; 1988 Jul; 10(3):149-58. PubMed ID: 3066776
    [Abstract] [Full Text] [Related]

  • 4. Effects of sulglycotide on endogenous prostaglandin synthesis in human antral mucosa.
    Calabrò A, Orsini B, Milani S, Psilogenis M, Surrenti C.
    Pharmacol Res; 1992 Dec; 26(4):403-7. PubMed ID: 1294942
    [Abstract] [Full Text] [Related]

  • 5. The effect of stress and indomethacin, carbenoxolone, salbutamol, metiamide, zolimidine and CF19415 on rat gastric mucus.
    Green AP, Lander JE, Turner DH.
    J Pharm Pharmacol; 1981 Jun; 33(6):348-52. PubMed ID: 6115004
    [No Abstract] [Full Text] [Related]

  • 6. Anti-ulcer activity of carbenoxolone and ISF 3401 on PGE2 release in rat gastric mucosa.
    Franco L, Manara P, Erbetti I, Velo GP.
    Pharmacol Res; 1993 Jun; 27(2):141-50. PubMed ID: 8474959
    [Abstract] [Full Text] [Related]

  • 7. Antiulcer and gastroprotective effects of quercetin: a gross and histologic study.
    Alarcón de la Lastra C, Martín MJ, Motilva V.
    Pharmacology; 1994 Jan; 48(1):56-62. PubMed ID: 8309988
    [Abstract] [Full Text] [Related]

  • 8. Protective effects of escin against indomethacin-induced gastric ulcer in mice.
    Wang T, Zhao S, Wang Y, Yang Y, Yao L, Chu L, Du H, Fu F.
    Toxicol Mech Methods; 2014 Dec; 24(8):560-6. PubMed ID: 25137224
    [Abstract] [Full Text] [Related]

  • 9. Enhancement in gastric mucosal epidermal growth factor receptor expression by sulglycotide.
    Slomiany BL, Piotrowski J, Czajkowski A, Murty VL, Majka J, Slomiany A.
    Biochem Mol Biol Int; 1994 May; 33(2):229-34. PubMed ID: 7951043
    [Abstract] [Full Text] [Related]

  • 10. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats.
    Martín MJ, Marhuenda E, Pérez-Guerrero C, Franco JM.
    Pharmacology; 1994 Sep; 49(3):144-50. PubMed ID: 7972328
    [Abstract] [Full Text] [Related]

  • 11. Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide.
    Slomiany BL, Piotrowski J, Slomiany A.
    Gen Pharmacol; 1999 Feb; 32(2):251-7. PubMed ID: 10188628
    [Abstract] [Full Text] [Related]

  • 12. 15-PGDH inhibitors: the antiulcer effects of carbenoxolone, pioglitazone and verapamil in indomethacin induced peptic ulcer rats.
    Moustafa YM, El-Azab MF, Fouda A.
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(15):2000-9. PubMed ID: 23884819
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying.
    Robert A, Olafsson AS, Lancaster C, Zhang WR.
    Life Sci; 1991 Feb; 48(2):123-34. PubMed ID: 1825231
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of sulglycotide on human gastric mucosa exposed to taurocholic acid.
    Corinaldesi R, Zurita J, Cenedese A, Stanghellini V, Cavalli G, Paparo G, Barbara L.
    Int J Clin Pharmacol Res; 1987 Feb; 7(2):101-4. PubMed ID: 3583492
    [Abstract] [Full Text] [Related]

  • 15. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G, Montrone F, Petrillo M, Caruso I, Ardizzone S.
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [Abstract] [Full Text] [Related]

  • 16. Effect of stobadine on indomethacin- and ethanol-induced stomach lesions and gastric secretion.
    Mirossay L, Kohút A.
    Physiol Res; 1991 Oct; 40(4):437-40. PubMed ID: 1811722
    [Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide.
    Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL.
    Gen Pharmacol; 1993 Nov; 24(6):1467-72. PubMed ID: 8112522
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide.
    Murty VL, Piotrowski J, Czajkowski A, Slomiany A, Slomiany BL.
    Gen Pharmacol; 1993 Nov; 24(6):1463-6. PubMed ID: 8112521
    [Abstract] [Full Text] [Related]

  • 19. Gastro-protective effect of methanol extract of Ficus asperifolia bark on indomethacin-induced gastric ulcer in rats.
    Raji Y, Oyeyemi WA, Shittu ST, Bolarinwa AF.
    Niger J Physiol Sci; 2011 Nov 23; 26(1):43-8. PubMed ID: 22314986
    [Abstract] [Full Text] [Related]

  • 20. Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury.
    Pineda-Peña EA, Jiménez-Andrade JM, Castañeda-Hernández G, Chávez-Piña AE.
    Eur J Pharmacol; 2012 Dec 15; 697(1-3):139-43. PubMed ID: 23063544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.